Differential Responses of Human iPSC-Derived Microglia to Stimulation with Diverse Inflammogens
Human microglia are central regulators and actors in brain infections and neuro-inflammatory pathologies. However, access to such cells is limited, and studies systematically mapping the spectrum of their inflammatory states are scarce. Here, we generated microglia-like cells (MGLCs) from human induced pluripotent stem cells and characterized them as a robust, accessible model system for studying inflammatory activation. We validated lineage identity through transcriptome profiling, revealing selective upregulation of microglial signature genes and enrichment of microglia/macrophage-related gene sets. MGLCs displayed distinct morphologies and produced stimulus- and time-dependent cytokine secretion profiles upon exposure to diverse inflammatory stimuli, including pro-inflammatory cytokines (TNFα, interferon-γ) and agonists of the Toll-like receptors TLR2 (FSL-1), TLR3 (Poly(I:C)), TLR4 (lipopolysaccharide, LPS), and TLR7 (imiquimod). Transcriptome profiling and bioinformatics analysis revealed distinct activation signatures. Functional assays demonstrated stimulus-specific engagement of NFκB and JAK-STAT signaling pathways. The shared NFκB nuclear translocation response of TLR ligands and TNFα was reflected in overlapping transcriptome profiles: they shared modules (e.g., oxidative stress response and TNFα-related signaling) identified by weighted gene co-expression network analysis. Finally, the potential consequences of microglia activation for neighboring cells were studied on the example of microglia-astrocyte crosstalk. The capacity of MGLC supernatants to stimulate astrocytes was measured by quantifying astrocytic NFκB translocation. MGLCs stimulated with FSL-1, LPS, or Poly(I:C) indirectly activated astrocytes via a strictly TNFα-dependent mechanism, highlighting the role of soluble mediators in the signal propagation. Altogether, this platform enables a dissection of microglia activation states and multi-parametric characterization of subsequent neuroinflammation.
Authors
- Heidrun Leisner
- Oliver Poetz (ORCID: https://orcid.org/0000-0002-1189-9547)
- Marcel Leist (ORCID: https://orcid.org/0000-0002-3778-8693)
- Nicole Schneiderhan‐Marra (ORCID: https://orcid.org/0000-0001-6785-181X)
- Markus Brüll
- Nadine Dreser (ORCID: https://orcid.org/0000-0002-7103-0990)
- Julian Suess
- Thomas Härtung (ORCID: https://orcid.org/0000-0003-1359-7689)
- Madeleine Fandrich (ORCID: https://orcid.org/0009-0007-5750-7274)
- Chiara Wolfbeisz
Institutions
- Johns Hopkins University (US)
- University of Konstanz (DE)
- Johns Hopkins Medicine (US)
- Signatope GmbH (Germany)
- University of Tübingen (DE)
Publication Details
- Journal
- Cells
- Published
- 2025-10-28
- DOI
- https://doi.org/10.3390/cells14211687
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Chemical Industry Council
- Aimmune Therapeutics
- European Commission
- Universität Konstanz